The Dalmia Group has agreed to acquire a 26% stake in Religare Health Insurance, as part of a consortium of investors that is buying 80% of the company from Religare Enterprises for US$161 million. Other members of the consortium include True North Group (formerly India Value Fund) and Faering Capital.
The deal is the single largest investment in the history of India’s health insurance industry.
Khaitan & Co advised the Dalmia Group. The corporate team comprised partner Bharat Anand and senior associates Siddharth Sawhney, Sanchit Agarwal and Kevin Peter. They were assisted on regulatory aspects by partner Anuj Sah and senior associate Rohan Singh.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
